Corticosteroid treatment for alcohol-related hepatitis
NICE ()
It is not recomended due to:
- has been shown to improve survival in the short term (1 month)
- has not been shown to improve survival over a longer term (3 months to 1 year)
- has been shown to increase the risk of serious infections within the first 3 months of starting treatment.